Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 90.9% in March

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 18,900 shares, an increase of 90.9% from the March 15th total of 9,900 shares. Currently, 0.7% of the company’s stock are short sold. Based on an average trading volume of 8,200 shares, the short-interest ratio is presently 2.3 days.

Analyst Upgrades and Downgrades

AEMD has been the subject of several recent analyst reports. HC Wainwright lowered their target price on shares of Aethlon Medical from $23.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, March 4th. StockNews.com initiated coverage on shares of Aethlon Medical in a research note on Friday. They issued a “sell” rating for the company.

Hedge Funds Weigh In On Aethlon Medical

Institutional investors and hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC raised its stake in Aethlon Medical by 11.6% during the first quarter. Renaissance Technologies LLC now owns 270,297 shares of the medical equipment provider’s stock worth $395,000 after purchasing an additional 28,097 shares during the period. Two Sigma Investments LP purchased a new stake in shares of Aethlon Medical in the 3rd quarter valued at approximately $32,000. HRT Financial LP purchased a new stake in shares of Aethlon Medical in the 4th quarter valued at approximately $28,000. Citadel Advisors LLC purchased a new stake in Aethlon Medical during the 3rd quarter worth approximately $72,000. Finally, Jane Street Group LLC increased its stake in Aethlon Medical by 895.7% during the 4th quarter. Jane Street Group LLC now owns 140,245 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 126,160 shares during the period. 1.99% of the stock is currently owned by institutional investors and hedge funds.

Aethlon Medical Stock Down 4.9 %

Shares of NASDAQ AEMD opened at $1.56 on Friday. The company’s 50-day simple moving average is $1.71 and its 200-day simple moving average is $1.80. Aethlon Medical has a 52-week low of $1.40 and a 52-week high of $7.20. The firm has a market cap of $4.09 million, a price-to-earnings ratio of -0.31 and a beta of 1.88.

Aethlon Medical (NASDAQ:AEMD) last announced its earnings results on Wednesday, February 14th. The medical equipment provider reported ($1.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.23) by ($0.14). Equities research analysts anticipate that Aethlon Medical will post -4.98 EPS for the current fiscal year.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.